Trial Profile
Ultrasonographic characterization of small nodules in cirrhotic patients using contrast media through splancnic infusion
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Liver cirrhosis
- Focus Diagnostic use
- 31 Jul 2022 Status changed from recruiting to discontinued.
- 03 Apr 2014 New trial record